drugset
drugset / Trial / NCT03793621

This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 730357 Are Taken up in the Body and How Well They Are Tolerated

NCT03793621 ↗

Phase 1 Completed 24 enrolled Boehringer Ingelheim
RandomizedParallel-groupDouble-blindTreatment

Summary

The main objective of this trial is to investigate the safety and tolerability of BI 730357 in Japanese healthy male subjects following oral administration of single rising doses. Secondary objectives are the explorations of the pharmacokinetic(s) (PK), including dose proportionality as well as investigation of linearity of BI 730357 after single dose administration.

Timeline

Start
2019-01-21
Primary completion
2019-04-26
Completion
2019-04-26

Drugs

EvaluationDrugModalityDoseRoute
Subject BI 730357 Unknown — Oral

Indications

No indication recorded.